Back to top

Image: Bigstock

MODV or CRL: Which Is the Better Value Stock Right Now?

Read MoreHide Full Article

Investors interested in Medical Services stocks are likely familiar with ModivCare (MODV - Free Report) and Charles River Laboratories (CRL - Free Report) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.

Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.

ModivCare and Charles River Laboratories are sporting Zacks Ranks of #2 (Buy) and #3 (Hold), respectively, right now. The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that MODV has an improving earnings outlook. But this is just one piece of the puzzle for value investors.

Value investors are also interested in a number of tried-and-true valuation metrics that help show when a company is undervalued at its current share price levels.

The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors.

MODV currently has a forward P/E ratio of 27.99, while CRL has a forward P/E of 39.74. We also note that MODV has a PEG ratio of 2.80. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. CRL currently has a PEG ratio of 2.84.

Another notable valuation metric for MODV is its P/B ratio of 6.15. The P/B ratio pits a stock's market value against its book value, which is defined as total assets minus total liabilities. For comparison, CRL has a P/B of 8.83.

These metrics, and several others, help MODV earn a Value grade of B, while CRL has been given a Value grade of C.

MODV has seen stronger estimate revision activity and sports more attractive valuation metrics than CRL, so it seems like value investors will conclude that MODV is the superior option right now.

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

ModivCare Inc. (MODV) - free report >>

Charles River Laboratories International, Inc. (CRL) - free report >>

Published in